CALQUENCE plus venetoclax demonstrated statistically significant and clinically meaningful improvement in progression-free survival vs. chemoimmunotherapy, with 77% of patients progression free at three...
Our top chart strategist explains what investors are missing amid all the chatter over software stocks and AI spending; plus, his favorite stock to trade right now.
/AI%20(artificial%20intelligence)/3D%20Graphics%20Concept%20Big%20Data%20Center%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
Norway's sovereign wealth fund invested $200 million in IonQ, $39 million in Rigetti, and $4 million in D-Wave. Wedbush sees this as a potential turning point for institutional investment in quantum computing...
Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide/glycopyrronium/formoterol...
With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.
US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date
EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END
Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period
/Alphabet%20Inc_%20and%20Google%20logos%20seen%20displayed%20on%20a%20smartphone%20by%20IgorGolovniov%20via%20Shutterstock.jpg)
Find out what’s on the desk of our top chart expert ahead of Friday’s livestream, including a new red flag on Google stock, a big breakout in BALL, and key ETF updates.
Michael Burry made a fortune betting against the U.S. housing market. He believes GameStop CEO Ryan Cohen is a Warren Buffett in waiting. Here are three reasons why that’s not the case and why bullish...